Trieste, Italy

Gabriele Ugolini

USPTO Granted Patents = 1 


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gabriele Ugolini: Innovator in Antibody Development

Introduction

Gabriele Ugolini is a notable inventor based in Trieste, Italy. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for medical applications. His work focuses on innovative solutions that address critical health challenges.

Latest Patents

Ugolini holds a patent for "Anti-TrkA antibodies, derivatives and uses thereof." This invention pertains to an antibody, as well as recombinant or synthetic antigen-binding fragments that can recognize and bind to an epitope within the TrkA amino acid sequence. The patent outlines the medical uses of these antibodies and includes a pharmaceutical composition that comprises at least one of the aforementioned antibody fragments.

Career Highlights

Gabriele Ugolini is associated with Rottapharm Biotech S.r.l., a company known for its focus on biopharmaceuticals. His work at the company has been instrumental in advancing research and development in the field of antibody therapies.

Collaborations

Ugolini collaborates with esteemed colleagues such as Lucio C Rovati and Michela Visintin. Their combined expertise contributes to the innovative projects undertaken at Rottapharm Biotech S.r.l.

Conclusion

Gabriele Ugolini's contributions to antibody development exemplify the impact of innovation in biotechnology. His patent on Anti-TrkA antibodies showcases his commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…